生命科学资讯

Meningeal blood vessel blockage enhances anti-glioblastoma immunity

Molecular architecture of human dermal sleeping nociceptors

Divergent tumor immunity determined by bacteria-cancer cell engagement

Flagship-founded antibody biotech Generate is latest to mull IPO

A cut above: Veradermics locks in $256M IPO and shares spike

Angitia raises $130M to challenge Amgen with bone-building bispecifics

GE HealthCare posts higher full-year revenues amid turbulent tariff backdrop

Bristol Myers draws pipeline excitement as several data readouts near

GLP-1s and the Super Bowl

Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex

Illumina earnings loom as investors seek clarity on 2026 outlook By Investing.com - Investing.com

Telehealth provider Hims goes after Novo's weight loss pill with compounded version

Polar Bears, Shrinking Sea Ice and a Scientific Surprise

Eikon IPO analysis: Big biotech names, big valuation cut

The most valuable up-and-coming GLP-1s

Big Pharma CEOs set sights on massive growth in years to come

Yichang Humanwell Pharma divulges new benzodiazepine compounds

The United Bio-Technology discloses new GLP-1R agonists

Chengdu companies patent new PET/SPECT imaging agents

Yichang Humanwell Pharma reports new KCNQ2/3 activators